- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
October 27, 2020
Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma.
October 26, 2020
Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes.
October 26, 2020
Dynamic 68Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study.
October 26, 2020
HIF1α is not a target of 14q deletion in clear cell renal cancer.
October 22, 2020
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
October 22, 2020
Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy.
October 21, 2020
Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma.
October 21, 2020
Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome.
October 20, 2020
Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers.
October 20, 2020
Association between copy-number alteration of +20q, -14q and -18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma.
October 20, 2020
Assessment for prognostic value of differentially expressed genes in immune microenvironment of clear cell renal cell carcinoma.
October 19, 2020
Biological functions and prognostic value of RNA Binding Proteins in clear cell Renal Cell Carcinoma.
October 19, 2020
TRIP13 predicts poor prognosis in clear cell renal cell carcinoma.
October 19, 2020